Healthcare Professional’s Experiences & Perceptions of Switching Brands of oral SACT – Survey

Dear BOPA members

In cancer care, little is known about the impact of specific brands of oral SACT medication or how healthcare professionals respond and process brand switches of oral SACT. To understand this, we would like to gather the views of healthcare professionals involved in cancer care, on their perspectives and experiences on brand switching of oral SACT. Insights will be combined with data from the NIHR-funded SWITCH project, to improve cancer treatment delivery.

We would be very grateful if you would complete this online survey, which will take 10-15 minutes, by scanning the QR code or through this link: https://qualtrics.ucl.ac.uk/jfe/form/SV_dj0l16wIjCFIbWe

If you have any problems please email Pinkie Chambers : [email protected]

We would like responses by November 28th

Many thanks
Jessica Lim

4th Year MPharm Student, UCL School of Pharmacy

Supervisors: Dr Pinkie Chambers, Dr Zoe Moon, Rebecca Todd

Latest News

By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article